Elite Journal of Health Sciences. Volume 2 issue 1(2024), Pp. 20-24 https://epjournals.com/journals/EJHS Citation: Mohamed QH and Obeagu EI. Genetic Heterogeneity in Breast Cancer: Implications. Elite Journal of Health Science, 2024; 2(1): 20-24 1 Genetic Heterogeneity in Breast Cancer: Implications Qali Hassan Mohamed and * Emmanuel Ifeanyi Obeagu Department of Medical Laboratory Science, Kampala International University, Uganda. Abstract Breast cancer, a heterogeneous disease with diverse molecular subtypes, presents a complex challenge in the realm of oncology. The recognition of genetic heterogeneity within breast cancer has revolutionized our understanding of its etiology and progression. This review aims to elucidate the implications of genetic diversity in breast cancer for the development of effective treatment strategies. Advancements in genomic profiling have revealed distinct molecular subtypes, each characterized by unique genetic alterations and expression profiles. The heterogeneity observed in breast cancer extends beyond histological classifications, influencing clinical outcomes and responses to therapy. This review explores the underlying genetic drivers of breast cancer heterogeneity, including mutations in key oncogenes and tumor suppressor genes, as well as alterations in DNA repair pathways. This paper provides a comprehensive overview of genetic heterogeneity in breast cancer and its far-reaching implications for treatment strategies. By understanding the molecular intricacies driving this heterogeneity, clinicians and researchers can advance towards personalized and more effective therapeutic interventions, ultimately improving the prognosis and quality of life for individuals affected by breast cancer. Keywords: Breast cancer, Genetic heterogeneity, Molecular subtypes, Treatment strategies, Precision medicine, Targeted therapies, Clonal evolution Introduction Breast cancer remains a formidable challenge in the realm of oncology, affecting millions of lives worldwide. The intricate nature of this disease is underscored by the diverse genetic landscapes it encompasses, giving rise to the phenomenon known as genetic heterogeneity. In recent years, the exploration of genetic heterogeneity in breast cancer has emerged as a pivotal avenue of research, holding profound implications for the development and refinement of treatment strategies. 1-5 The understanding of breast cancer has evolved beyond a singular, homogenous entity to a mosaic of distinct molecular subtypes. Genetic heterogeneity refers to the presence of varied genetic alterations and expressions within breast cancer tumors across different individuals. This diversity poses a challenge in devising effective and targeted treatment approaches, as the one-size-fits-all paradigm proves increasingly inadequate. Thus, unraveling the intricacies of genetic heterogeneity becomes imperative in tailoring interventions to the unique genetic profiles of individual patients. 6 Breast cancer is typically a highly heterogeneous disease. Breast tumor heterogeneity has been observed and described since the nineteenth century and these differences have served as the basis for disease classification in 1988 reported variations in estrogen receptor concentration due to variations in tissue cellularity. Breast tumor heterogeneity was observed among different patients (inter-tumor heterogeneity) and even within each individual tumor (intra-tumor heterogeneity),